Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05919563 · ClinicalTrials.gov registry record
LTFU Study of Subjects Who Received GRNOPC1
A clinical trial of Spinal Cord Injuries, sponsored by Lineage Cell Therapeutics.
- Active
- Registry status
- 5
- Enrollment target
- 3
- Study locations
NCT05919563: Active study of Spinal Cord Injuries, sponsored by Lineage Cell Therapeutics.
NCT05919563 is a study of Spinal Cord Injuries that is active but no longer recruiting, run by Lineage Cell Therapeutics. The registered enrollment target is 5 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05919563, a study of Spinal Cord Injuries, is active but no longer recruiting, sponsored by Lineage Cell Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 5 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a LTFU study for thoracic SCI subjects that were administered GRNOPC1 cells in the main study CP35A007.
Primary Outcome
Information will be collected on all adverse events through Year 5 and on late-occurring adverse events (Years 6-15) related to any changes in neurological condition, a fever of unknown etiology, and the development of neoplasias and/or neurological disorders.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging (MRI)
Study Locations (3)
California
- Stanford University - Palo Alto
Georgia
- Shepherd Center - Atlanta
Illinois
- Northwestern Medical Group - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-10-06 |
| Est. Completion | 2026-12-12 |
What the registry record for NCT05919563 still lists
NCT05919563 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT05919563 reports a single indexed study location in California, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT05919563 about?
NCT05919563 is a clinical study titled "LTFU Study of Subjects Who Received GRNOPC1". This is a LTFU study for thoracic SCI subjects that were administered GRNOPC1 cells in the main study CP35A007.
What is the current status of trial NCT05919563?
This trial is currently active not recruiting. The enrollment target is 5 participants. The study started on 2011-10-06. Estimated completion is 2026-12-12.
What conditions does trial NCT05919563 study?
This clinical trial studies the following conditions: Spinal Cord Injuries.
What interventions are being tested in trial NCT05919563?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05919563?
This trial is sponsored by Lineage Cell Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05919563 being conducted?
This trial has 3 study locations across California, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05919563's enrollment target sits among peer trials
5 190th of 202 higher than 8 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Effectiveness of the Collaborative Community Clinic for Persons With Spinal Cord Injury and Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy